Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06843330 · ClinicalTrials.gov registry record
Accuracy of Lactate Meter in GSDIa
A clinical trial of Glycogen Storage Disease Type Ia, sponsored by Connecticut Children's Medical Center.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT06843330 is a study of Glycogen Storage Disease Type Ia that is actively recruiting participants, run by Connecticut Children's Medical Center. The registered enrollment target is 10 participants, below the 49-participant average among 5 other Glycogen Storage Disease Type Ia trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06843330, a study of Glycogen Storage Disease Type Ia, is actively recruiting participants, sponsored by Connecticut Children's Medical Center.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, in a population of patients with glycogen storage disease type 1a.
Conditions Studied
Interventions
- DEVICE blood glucose meter; blood lactate meter
Study Locations (1)
Connecticut
- Connecticut Children's Medical Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-04-14 |
| Est. Completion | 2027-12-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06843330
The ClinicalTrials.gov registry entry for NCT06843330 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 49-participant average among 5 other Glycogen Storage Disease Type Ia trials with a reported enrollment target (80% lower). The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glycogen Storage Disease Type Ia appearing as the primary indexed condition, and to 1 intervention - of which blood glucose meter; blood lactate meter is the first listed.
NCT06843330 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06843330 about?
NCT06843330 is a clinical study titled "Accuracy of Lactate Meter in GSDIa". The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurat...
What is the current status of trial NCT06843330?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-04-14. Estimated completion is 2027-12-10.
What conditions does trial NCT06843330 study?
This clinical trial studies the following conditions: Glycogen Storage Disease Type Ia.
What interventions are being tested in trial NCT06843330?
The interventions under investigation include: blood glucose meter; blood lactate meter (DEVICE).
Who is sponsoring clinical trial NCT06843330?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06843330 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glycogen Storage Disease Type Ia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
RECRUITING · Phase 1
-
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
RECRUITING
-
Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease
RECRUITING
-
A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)
COMPLETED · Phase 3
-
Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type Ia
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.